Status:
COMPLETED
High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborating Sponsors:
VA Puget Sound Health Care System
Washington D.C. Veterans Affairs Medical Center
Conditions:
COPD
HIV/AIDS
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist...
Detailed Description
Emerging data support that barriers to high quality COPD care are likely accentuated in HIV+ persons. Taken together, decreased recognition of smoking, lack of referral for pulmonary evaluation, worse...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Providers:
- • Outpatient infectious disease providers at one of the seven local sites participating in this study.
- Patients:
- • HIV+ patients with COPD treated by providers enrolled in the study.
- Exclusion Criteria:
- Providers:
- • Trainees
- Patients:
- • Significant cognitive dysfunction, language barriers or severe psychiatric disorder, impairing ability to participate in surveys and interviews.
Exclusion
Key Trial Info
Start Date :
May 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03856879
Start Date
May 21 2019
End Date
May 31 2025
Last Update
July 30 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
2
VA Eastern Colorado Health Care System
Denver, Colorado, United States, 80012
3
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06111
4
Washington DC VA Medical Center
Washington D.C., District of Columbia, United States, 20422